Lenvima is taking on Bayer's Nexavar in liver cancer in Japan – a drug that has been on the market for around a decade. According to Hendler the uptake in Japan has been remarkable, and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback